BC
Broadfin Capital Portfolio holdings
AUM
$403M
This Quarter Return
+15.53%
1 Year Return
+74.97%
3 Year Return
+245.63%
5 Year Return
+336.04%
10 Year Return
–
AUM
$1.52B
AUM Growth
+$1.52B
(+21%)
Cap. Flow
+$94.4M
Cap. Flow
% of AUM
6.2%
Top 10 Holdings %
Top 10 Hldgs %
46.09%
Holding
98
New
17
Increased
26
Reduced
19
Closed
7
Top Buys
| 1 |
NVRO
NEVRO CORP.
NVRO
|
$22.6M |
| 2 |
RPTP
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
|
$20.8M |
| 3 |
PTX
Pernix Therapeutics Holdings, Inc.
PTX
|
$17.2M |
| 4 |
Zevra Therapeutics
ZVRA
|
$15.2M |
| 5 |
CYNA
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
|
$13.9M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$77.7M |
| 2 |
Travere Therapeutics
TVTX
|
$26.5M |
| 3 |
Heron Therapeutics
HRTX
|
$12.8M |
| 4 |
Amphastar Pharmaceuticals
AMPH
|
$12.5M |
| 5 |
UAM
Universal American Corp
UAM
|
$12.1M |
Sector Composition
| 1 | Healthcare | 92.68% |
